Calcineurin mediates calcium-induced potentiation of adenylyl cyclase activity in dispersed chief cells from guinea pig stomach. Further evidence for cross-talk between signal transduction pathways that regulate pepsinogen secretion

In cholera toxin-treated gastric chief cells, incubation with a cholinergic agonist (carbamylcholine), a regulatory peptide (cholecystokinin), or a calcium ionophore (A23187) causes a dose- and time-dependent potentiation of cAMP levels. Because this augmented response is calcium/calmodulin-dependen...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of biological chemistry 1996-08, Vol.271 (33), p.19877-19882
Hauptverfasser: Raufman, J P, Lin, J, Raffaniello, R D
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 19882
container_issue 33
container_start_page 19877
container_title The Journal of biological chemistry
container_volume 271
creator Raufman, J P
Lin, J
Raffaniello, R D
description In cholera toxin-treated gastric chief cells, incubation with a cholinergic agonist (carbamylcholine), a regulatory peptide (cholecystokinin), or a calcium ionophore (A23187) causes a dose- and time-dependent potentiation of cAMP levels. Because this augmented response is calcium/calmodulin-dependent, we hypothesized that it was mediated by calcineurin (protein phosphatase 2B). To test this hypothesis, we examined the actions of calcineurin inhibitors on secretagogue-induced potentiation of cAMP levels in guinea pig chief cells. Preincubation of cells with 0.1 microM FK-506 completely prevented carbachol-induced augmentation of cAMP levels and pepsinogen secretion from cholera toxin-treated cells. Cyclosporin-A, another calcineurin inhibitor, also prevented the augmented cAMP response. FK-506 and cyclosporin inhibited augmentation of cAMP levels following treatment with cholecystokinin(26-33) and A23187, but not the smaller increase in cAMP following treatment with a phorbol ester that activates protein kinase C. Hence, the actions of calcineurin inhibitors were limited to secretagogues that increase cellular calcium. Rapamycin, an agent that competes with FK-506 for the immunophilin, FK binding protein 12, does not inhibit calcineurin. In the present study, preincubation with rapamycin did not prevent carbachol-induced augmentation of cAMP levels in cholera toxin-treated chief cells. However, a molar excess of rapamycin reversed the inhibitory actions of FK-506. These experiments provide further evidence that the actions of FK-506 on cholera toxin-treated gastric chief cells are caused by its inhibitory actions on calcineurin. FK-506 also inhibited potentiation of cAMP levels when carbachol was added to cells that were preincubated with forskolin, an agent that directly activates adenylyl cyclase. We conclude that, in gastric chief cells, calcineurin mediates cross-talk between the calcium/calmodulin and adenylyl cyclase signaling pathways.
doi_str_mv 10.1074/jbc.271.33.19877
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_15671833</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>15671833</sourcerecordid><originalsourceid>FETCH-LOGICAL-p169t-f3563aa8d68e3654af0f18da0b64cf8d1ca487c53f3d5d621383d967fe20add83</originalsourceid><addsrcrecordid>eNotUU1v1TAQzKGolMKdC9KeuCXEcT6cI3qiUKkSFzg_7bPXiVvHDrbTKv-Yn4EffXtZaXdmdjRbFB9ZXbF6aL88nmTVDKzivGKjGIar4qauG1aOTSfeFu9ifKxztSO7Lq7FUDf9ON4Ufw9opXG0BeNgIWUwUQR5Hm5LaZzaJClYfSKX8s54B14DKnK73S3IXVqMBCiTeTZph6yiTFwpxEyTsyENkqyNoINfYNryKYTVTBCTX1DOFdxtIc0UgJ5NVpUE2geQwcdYJrRPcKL0QuQgmsmhhRTQxezqv5UV0_yCe4Q0Y4JA02azf1hpjcb56cwiGeiMfV-80Wgjfbj02-L33bdfhx_lw8_v94evD-XK-jGVmnc9RxSqF8T7rkVdayYU1qe-lVooJrEVg-y45qpTfcO44GrsB01NjUoJflt8ftVdg_-zUUzHxcRzBOjIb_HIun5ggvMM_HQBbqcc_HENZsGwHy-v4f8AnOaX7Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>15671833</pqid></control><display><type>article</type><title>Calcineurin mediates calcium-induced potentiation of adenylyl cyclase activity in dispersed chief cells from guinea pig stomach. Further evidence for cross-talk between signal transduction pathways that regulate pepsinogen secretion</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Raufman, J P ; Lin, J ; Raffaniello, R D</creator><creatorcontrib>Raufman, J P ; Lin, J ; Raffaniello, R D</creatorcontrib><description>In cholera toxin-treated gastric chief cells, incubation with a cholinergic agonist (carbamylcholine), a regulatory peptide (cholecystokinin), or a calcium ionophore (A23187) causes a dose- and time-dependent potentiation of cAMP levels. Because this augmented response is calcium/calmodulin-dependent, we hypothesized that it was mediated by calcineurin (protein phosphatase 2B). To test this hypothesis, we examined the actions of calcineurin inhibitors on secretagogue-induced potentiation of cAMP levels in guinea pig chief cells. Preincubation of cells with 0.1 microM FK-506 completely prevented carbachol-induced augmentation of cAMP levels and pepsinogen secretion from cholera toxin-treated cells. Cyclosporin-A, another calcineurin inhibitor, also prevented the augmented cAMP response. FK-506 and cyclosporin inhibited augmentation of cAMP levels following treatment with cholecystokinin(26-33) and A23187, but not the smaller increase in cAMP following treatment with a phorbol ester that activates protein kinase C. Hence, the actions of calcineurin inhibitors were limited to secretagogues that increase cellular calcium. Rapamycin, an agent that competes with FK-506 for the immunophilin, FK binding protein 12, does not inhibit calcineurin. In the present study, preincubation with rapamycin did not prevent carbachol-induced augmentation of cAMP levels in cholera toxin-treated chief cells. However, a molar excess of rapamycin reversed the inhibitory actions of FK-506. These experiments provide further evidence that the actions of FK-506 on cholera toxin-treated gastric chief cells are caused by its inhibitory actions on calcineurin. FK-506 also inhibited potentiation of cAMP levels when carbachol was added to cells that were preincubated with forskolin, an agent that directly activates adenylyl cyclase. We conclude that, in gastric chief cells, calcineurin mediates cross-talk between the calcium/calmodulin and adenylyl cyclase signaling pathways.</description><identifier>ISSN: 0021-9258</identifier><identifier>DOI: 10.1074/jbc.271.33.19877</identifier><identifier>PMID: 8702699</identifier><language>eng</language><publisher>United States</publisher><subject>Adenylyl Cyclases - metabolism ; Animals ; Calcimycin - pharmacology ; Calcineurin ; Calcium - physiology ; Calmodulin-Binding Proteins - antagonists &amp; inhibitors ; Calmodulin-Binding Proteins - pharmacology ; Carbachol - pharmacology ; Cells, Cultured ; Cholecystokinin - pharmacology ; Cholera Toxin - pharmacology ; Cyclic AMP - metabolism ; Cycloheximide - pharmacology ; Cyclosporine - pharmacology ; Ethers, Cyclic - pharmacology ; Guinea Pigs ; Male ; Okadaic Acid ; Pepsinogens - metabolism ; Phosphodiesterase Inhibitors - pharmacology ; Phosphoprotein Phosphatases - antagonists &amp; inhibitors ; Phosphoprotein Phosphatases - pharmacology ; Polyenes - pharmacology ; Signal Transduction ; Sirolimus ; Stomach - cytology ; Stomach - enzymology ; Tacrolimus - pharmacology</subject><ispartof>The Journal of biological chemistry, 1996-08, Vol.271 (33), p.19877-19882</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8702699$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Raufman, J P</creatorcontrib><creatorcontrib>Lin, J</creatorcontrib><creatorcontrib>Raffaniello, R D</creatorcontrib><title>Calcineurin mediates calcium-induced potentiation of adenylyl cyclase activity in dispersed chief cells from guinea pig stomach. Further evidence for cross-talk between signal transduction pathways that regulate pepsinogen secretion</title><title>The Journal of biological chemistry</title><addtitle>J Biol Chem</addtitle><description>In cholera toxin-treated gastric chief cells, incubation with a cholinergic agonist (carbamylcholine), a regulatory peptide (cholecystokinin), or a calcium ionophore (A23187) causes a dose- and time-dependent potentiation of cAMP levels. Because this augmented response is calcium/calmodulin-dependent, we hypothesized that it was mediated by calcineurin (protein phosphatase 2B). To test this hypothesis, we examined the actions of calcineurin inhibitors on secretagogue-induced potentiation of cAMP levels in guinea pig chief cells. Preincubation of cells with 0.1 microM FK-506 completely prevented carbachol-induced augmentation of cAMP levels and pepsinogen secretion from cholera toxin-treated cells. Cyclosporin-A, another calcineurin inhibitor, also prevented the augmented cAMP response. FK-506 and cyclosporin inhibited augmentation of cAMP levels following treatment with cholecystokinin(26-33) and A23187, but not the smaller increase in cAMP following treatment with a phorbol ester that activates protein kinase C. Hence, the actions of calcineurin inhibitors were limited to secretagogues that increase cellular calcium. Rapamycin, an agent that competes with FK-506 for the immunophilin, FK binding protein 12, does not inhibit calcineurin. In the present study, preincubation with rapamycin did not prevent carbachol-induced augmentation of cAMP levels in cholera toxin-treated chief cells. However, a molar excess of rapamycin reversed the inhibitory actions of FK-506. These experiments provide further evidence that the actions of FK-506 on cholera toxin-treated gastric chief cells are caused by its inhibitory actions on calcineurin. FK-506 also inhibited potentiation of cAMP levels when carbachol was added to cells that were preincubated with forskolin, an agent that directly activates adenylyl cyclase. We conclude that, in gastric chief cells, calcineurin mediates cross-talk between the calcium/calmodulin and adenylyl cyclase signaling pathways.</description><subject>Adenylyl Cyclases - metabolism</subject><subject>Animals</subject><subject>Calcimycin - pharmacology</subject><subject>Calcineurin</subject><subject>Calcium - physiology</subject><subject>Calmodulin-Binding Proteins - antagonists &amp; inhibitors</subject><subject>Calmodulin-Binding Proteins - pharmacology</subject><subject>Carbachol - pharmacology</subject><subject>Cells, Cultured</subject><subject>Cholecystokinin - pharmacology</subject><subject>Cholera Toxin - pharmacology</subject><subject>Cyclic AMP - metabolism</subject><subject>Cycloheximide - pharmacology</subject><subject>Cyclosporine - pharmacology</subject><subject>Ethers, Cyclic - pharmacology</subject><subject>Guinea Pigs</subject><subject>Male</subject><subject>Okadaic Acid</subject><subject>Pepsinogens - metabolism</subject><subject>Phosphodiesterase Inhibitors - pharmacology</subject><subject>Phosphoprotein Phosphatases - antagonists &amp; inhibitors</subject><subject>Phosphoprotein Phosphatases - pharmacology</subject><subject>Polyenes - pharmacology</subject><subject>Signal Transduction</subject><subject>Sirolimus</subject><subject>Stomach - cytology</subject><subject>Stomach - enzymology</subject><subject>Tacrolimus - pharmacology</subject><issn>0021-9258</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNotUU1v1TAQzKGolMKdC9KeuCXEcT6cI3qiUKkSFzg_7bPXiVvHDrbTKv-Yn4EffXtZaXdmdjRbFB9ZXbF6aL88nmTVDKzivGKjGIar4qauG1aOTSfeFu9ifKxztSO7Lq7FUDf9ON4Ufw9opXG0BeNgIWUwUQR5Hm5LaZzaJClYfSKX8s54B14DKnK73S3IXVqMBCiTeTZph6yiTFwpxEyTsyENkqyNoINfYNryKYTVTBCTX1DOFdxtIc0UgJ5NVpUE2geQwcdYJrRPcKL0QuQgmsmhhRTQxezqv5UV0_yCe4Q0Y4JA02azf1hpjcb56cwiGeiMfV-80Wgjfbj02-L33bdfhx_lw8_v94evD-XK-jGVmnc9RxSqF8T7rkVdayYU1qe-lVooJrEVg-y45qpTfcO44GrsB01NjUoJflt8ftVdg_-zUUzHxcRzBOjIb_HIun5ggvMM_HQBbqcc_HENZsGwHy-v4f8AnOaX7Q</recordid><startdate>19960816</startdate><enddate>19960816</enddate><creator>Raufman, J P</creator><creator>Lin, J</creator><creator>Raffaniello, R D</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7QP</scope></search><sort><creationdate>19960816</creationdate><title>Calcineurin mediates calcium-induced potentiation of adenylyl cyclase activity in dispersed chief cells from guinea pig stomach. Further evidence for cross-talk between signal transduction pathways that regulate pepsinogen secretion</title><author>Raufman, J P ; Lin, J ; Raffaniello, R D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p169t-f3563aa8d68e3654af0f18da0b64cf8d1ca487c53f3d5d621383d967fe20add83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Adenylyl Cyclases - metabolism</topic><topic>Animals</topic><topic>Calcimycin - pharmacology</topic><topic>Calcineurin</topic><topic>Calcium - physiology</topic><topic>Calmodulin-Binding Proteins - antagonists &amp; inhibitors</topic><topic>Calmodulin-Binding Proteins - pharmacology</topic><topic>Carbachol - pharmacology</topic><topic>Cells, Cultured</topic><topic>Cholecystokinin - pharmacology</topic><topic>Cholera Toxin - pharmacology</topic><topic>Cyclic AMP - metabolism</topic><topic>Cycloheximide - pharmacology</topic><topic>Cyclosporine - pharmacology</topic><topic>Ethers, Cyclic - pharmacology</topic><topic>Guinea Pigs</topic><topic>Male</topic><topic>Okadaic Acid</topic><topic>Pepsinogens - metabolism</topic><topic>Phosphodiesterase Inhibitors - pharmacology</topic><topic>Phosphoprotein Phosphatases - antagonists &amp; inhibitors</topic><topic>Phosphoprotein Phosphatases - pharmacology</topic><topic>Polyenes - pharmacology</topic><topic>Signal Transduction</topic><topic>Sirolimus</topic><topic>Stomach - cytology</topic><topic>Stomach - enzymology</topic><topic>Tacrolimus - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Raufman, J P</creatorcontrib><creatorcontrib>Lin, J</creatorcontrib><creatorcontrib>Raffaniello, R D</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><jtitle>The Journal of biological chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Raufman, J P</au><au>Lin, J</au><au>Raffaniello, R D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Calcineurin mediates calcium-induced potentiation of adenylyl cyclase activity in dispersed chief cells from guinea pig stomach. Further evidence for cross-talk between signal transduction pathways that regulate pepsinogen secretion</atitle><jtitle>The Journal of biological chemistry</jtitle><addtitle>J Biol Chem</addtitle><date>1996-08-16</date><risdate>1996</risdate><volume>271</volume><issue>33</issue><spage>19877</spage><epage>19882</epage><pages>19877-19882</pages><issn>0021-9258</issn><abstract>In cholera toxin-treated gastric chief cells, incubation with a cholinergic agonist (carbamylcholine), a regulatory peptide (cholecystokinin), or a calcium ionophore (A23187) causes a dose- and time-dependent potentiation of cAMP levels. Because this augmented response is calcium/calmodulin-dependent, we hypothesized that it was mediated by calcineurin (protein phosphatase 2B). To test this hypothesis, we examined the actions of calcineurin inhibitors on secretagogue-induced potentiation of cAMP levels in guinea pig chief cells. Preincubation of cells with 0.1 microM FK-506 completely prevented carbachol-induced augmentation of cAMP levels and pepsinogen secretion from cholera toxin-treated cells. Cyclosporin-A, another calcineurin inhibitor, also prevented the augmented cAMP response. FK-506 and cyclosporin inhibited augmentation of cAMP levels following treatment with cholecystokinin(26-33) and A23187, but not the smaller increase in cAMP following treatment with a phorbol ester that activates protein kinase C. Hence, the actions of calcineurin inhibitors were limited to secretagogues that increase cellular calcium. Rapamycin, an agent that competes with FK-506 for the immunophilin, FK binding protein 12, does not inhibit calcineurin. In the present study, preincubation with rapamycin did not prevent carbachol-induced augmentation of cAMP levels in cholera toxin-treated chief cells. However, a molar excess of rapamycin reversed the inhibitory actions of FK-506. These experiments provide further evidence that the actions of FK-506 on cholera toxin-treated gastric chief cells are caused by its inhibitory actions on calcineurin. FK-506 also inhibited potentiation of cAMP levels when carbachol was added to cells that were preincubated with forskolin, an agent that directly activates adenylyl cyclase. We conclude that, in gastric chief cells, calcineurin mediates cross-talk between the calcium/calmodulin and adenylyl cyclase signaling pathways.</abstract><cop>United States</cop><pmid>8702699</pmid><doi>10.1074/jbc.271.33.19877</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0021-9258
ispartof The Journal of biological chemistry, 1996-08, Vol.271 (33), p.19877-19882
issn 0021-9258
language eng
recordid cdi_proquest_miscellaneous_15671833
source MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Adenylyl Cyclases - metabolism
Animals
Calcimycin - pharmacology
Calcineurin
Calcium - physiology
Calmodulin-Binding Proteins - antagonists & inhibitors
Calmodulin-Binding Proteins - pharmacology
Carbachol - pharmacology
Cells, Cultured
Cholecystokinin - pharmacology
Cholera Toxin - pharmacology
Cyclic AMP - metabolism
Cycloheximide - pharmacology
Cyclosporine - pharmacology
Ethers, Cyclic - pharmacology
Guinea Pigs
Male
Okadaic Acid
Pepsinogens - metabolism
Phosphodiesterase Inhibitors - pharmacology
Phosphoprotein Phosphatases - antagonists & inhibitors
Phosphoprotein Phosphatases - pharmacology
Polyenes - pharmacology
Signal Transduction
Sirolimus
Stomach - cytology
Stomach - enzymology
Tacrolimus - pharmacology
title Calcineurin mediates calcium-induced potentiation of adenylyl cyclase activity in dispersed chief cells from guinea pig stomach. Further evidence for cross-talk between signal transduction pathways that regulate pepsinogen secretion
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T14%3A14%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Calcineurin%20mediates%20calcium-induced%20potentiation%20of%20adenylyl%20cyclase%20activity%20in%20dispersed%20chief%20cells%20from%20guinea%20pig%20stomach.%20Further%20evidence%20for%20cross-talk%20between%20signal%20transduction%20pathways%20that%20regulate%20pepsinogen%20secretion&rft.jtitle=The%20Journal%20of%20biological%20chemistry&rft.au=Raufman,%20J%20P&rft.date=1996-08-16&rft.volume=271&rft.issue=33&rft.spage=19877&rft.epage=19882&rft.pages=19877-19882&rft.issn=0021-9258&rft_id=info:doi/10.1074/jbc.271.33.19877&rft_dat=%3Cproquest_pubme%3E15671833%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=15671833&rft_id=info:pmid/8702699&rfr_iscdi=true